Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors-Reference-Cited by-同舟云学术

Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors

Published:2000-02 Issue:2 Volume:1 Page:195-203
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Trask Todd W.,Trask Rebecca P.,Aguilar-Cordova Estuardo,Shine H.David,Wyde Philip R.,Goodman J.Clay,Hamilton Winifred J.,Rojas-Martinez Augusto,Chen Shu-Hsia,Woo Savio L.C.,Grossman Robert G.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference53 articles.

1. American Cancer Society, 1999, 1999 New Facts and Figures: Estimated New Cancer Cases and Deaths, http://www.cancer.org/statistics/cff99/data/data_newCaseSex.html.

2. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome;Shrieve;J. Neurosurg.,1999

3. Survival and functional status after resection of recurrent glioblastoma multiforme;Barker;Neurosurgery,1998

4. Management of glioblastoma multiforme: With special reference to recurrence;Durmaz;Clin. Neurol. Neurosurg.,1997

5. Management of malignant glioma: Role of surgery in relation to multimodality therapy;Black;J. Neurovirol.,1998

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial;The Lancet Oncology;2023-09

2. Immunotherapy for Recurrent Glioma—From Bench to Bedside;Cancers;2023-06-30

3. Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma;Pharmaceuticals;2023-05-26

4. The Biocatalysis in Cancer Therapy;ACS Catalysis;2023-05-25

5. Combined Cytotoxic and Immune Therapy for Primary Adult High-Grade Glioma;2022-11-08